Article Text

PDF

Acetylcholine may be an autocrine growth factor for lung cancer
  1. A De-Soyza
  1. 1University of Newcastle, Newcastle NE2 4HH, UK anthony.de-soyza{at}ncl.ac.uk

Statistics from Altmetric.com

Researchers have recently shown that small cell lung cancer (SCLC) cell lines secrete acetylcholine (ACh) into tissue culture medium. Treatment of the cell lines in vitro with either muscarinic (atropine) or nicotinic (mecalmylamine) antagonists reduced cell growth in cell lines that produced high quantities of ACh. This effect of ACh inhibition was seen with both inhibitors but not with cell lines that had a low baseline level of ACh secretion. Previous data from the same group (Cancer Res 2003;63:214–2) found that 13 of 26 archival SCLC expressed the biosynthetic enzyme for ACh production, choline acetyltransferase. These studies show that SCLC can synthesise and secrete ACh, and that released non-neuronal ACh stimulates SCLC cell growth. Identification of this autocrine loop provides a potential new avenue for therapeutic intervention in SCLC cell lines that are high ACh secretors. These data also reinforce the importance of smoking cessation, given the potential of exogenous nicotine to promote tumour growth.

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.